Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Transgenomic, Inc. (TBIO) Starts Presentation at 25th Annual ROTH Conference

Transgenomic,  a biotechnology company, operates in three segments: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. For more information, visit the company’s Web site: http://www.transgenomic.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *